Evidence map›Paper›PMID 35994509›Full record

ArticlePLoS pathogens2022

An apical protein, Pcr2, is required for persistent movement by the human parasite Toxoplasma gondii.

Jonathan Munera Lopez, Isadonna F Tengganu, Jun Liu, John M Murray, Luisa F Arias Padilla, Ying Zhang, Peter T Brown, Laurence Florens, Ke Hu

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Atomic models of the Toxoplasma cell invasion machinery.Nature structural & molecular biology · 2026
    Article
  4. Article
  5. Transfection of the free-living algabioRxiv : the preprint server for biology · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Egress Regulatory Factors: HowPathogens (Basel, Switzerland) · 2023
    Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Jonathan Munera LopezBiodesign Center for Mechanisms of Evolution/School of Life Sciences, Arizona State University, Tempe, Arizona, United States of America.
Isadonna F TengganuBiodesign Center for Mechanisms of Evolution/School of Life Sciences, Arizona State University, Tempe, Arizona, United States of America.
Jun LiuDepartment of Biology, Indiana University, Bloomington, Indiana, United States of America.
John M MurrayBiodesign Center for Mechanisms of Evolution/School of Life Sciences, Arizona State University, Tempe, Arizona, United States of America.
Luisa F Arias PadillaBiodesign Center for Mechanisms of Evolution/School of Life Sciences, Arizona State University, Tempe, Arizona, United States of America.
Ying ZhangStowers Institute for Medical Research, Kansas City, Missouri, United States of America.
Peter T BrownDepartment of Physics and Center for Biological Physics, Arizona State University, Tempe, Arizona, United States of America.
Laurence FlorensStowers Institute for Medical Research, Kansas City, Missouri, United States of America.
Ke HuBiodesign Center for Mechanisms of Evolution/School of Life Sciences, Arizona State University, Tempe, Arizona, United States of America.ORCID 0000-0001-9778-7337
Arizona State University · USStowers Institute for Medical Research · USIndiana University Bloomington · US

Funding

Cytoskeletal machinery driving invasion by the human pathogen, Toxoplasma gondii.R01AI132463 · NIAID · TRUSTEES OF INDIANA UNIVERSITY · PI HU, KE · 2018 to 2022
$2.0M
NIAID NIH HHS R01 AI132463
6 · The paper itself

Abstract

The phylum Apicomplexa includes thousands of species of unicellular parasites that cause a wide range of human and animal diseases such as malaria and toxoplasmosis. To infect, the parasite must first initiate active movement to disseminate through tissue and invade into a host cell, and then cease moving once inside. The parasite moves by gliding on a surface, propelled by an internal cortical actomyosin-based motility apparatus. One of the most effective invaders in Apicomplexa is Toxoplasma gondii, which can infect any nucleated cell and any warm-blooded animal. During invasion, the parasite first makes contact with the host cell "head-on" with the apical complex, which features an elaborate cytoskeletal apparatus and associated structures. Here we report the identification and characterization of a new component of the apical complex, Preconoidal region protein 2 (Pcr2). Pcr2 knockout parasites replicate normally, but they are severely diminished in their capacity for host tissue destruction due to significantly impaired invasion and egress, two vital steps in the lytic cycle. When stimulated for calcium-induced egress, Pcr2 knockout parasites become active, and secrete effectors to lyse the host cell. Calcium-induced secretion of the major adhesin, MIC2, also appears to be normal. However, the movement of the Pcr2 knockout parasite is spasmodic, which drastically compromises egress. In addition to faulty motility, the ability of the Pcr2 knockout parasite to assemble the moving junction is impaired. Both defects likely contribute to the poor efficiency of invasion. Interestingly, actomyosin activity, as indicated by the motion of mEmerald tagged actin chromobody, appears to be largely unperturbed by the loss of Pcr2, raising the possibility that Pcr2 may act downstream of or in parallel with the actomyosin machinery.

Indexed as

ParasitesToxoplasmaActomyosinAnimalsCalciumHost-Parasite InteractionsHumansProtozoan ProteinsActomyosinCalciumProtozoan Proteins

Identifiers

PMID35994509
PMCPMC9436145
OpenAlexW4292635878

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.